Author | Kelly Davio

Risk of New IBD Rises for Patients Treated With Etanercept

January 01, 2020

While anti–tumor necrosis factor (anti-TNF) drugs are effective at treating a range of inflammatory diseases, some limited data suggest that they may, paradoxically, result in a higher risk of developing other de novo inflammatory conditions.